The Simoa plasma assay did not correlate with the CSF nor the MS method, where in CSF the NPTX2 levels were decreased in AD compared to CU, whereas the plasma results showed a tendency to be increased in AD compared to controls, which has been previously shown.67 Here, NPTX2 is linked to Alzheimer disease.